Skip to content
10-Q

Quarterly Report

BIOMET INC

0001402366-14-000020

← back to feed
Filed
Oct 14, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Sep 30, 2014 552.55M sh
Capex Q1 2015 · Aug 31, 2014 $60.8M
Capex Q1 2015 · Aug 31, 2013 $46.5M
Operating Cash Flow Q1 2015 · Aug 31, 2014 $2.4M
Operating Cash Flow Q1 2015 · Aug 31, 2013 $50.8M
Long Term Debt Q1 2015 · Aug 31, 2014 $5.6B
Long Term Debt Q1 2015 · May 31, 2014 $5.59B
Cash And Equivalents Q1 2015 · Aug 31, 2014 $192M
Cash And Equivalents Q1 2015 · May 31, 2014 $247.6M
Cash And Equivalents Q1 2015 · Aug 31, 2013 $345.4M
Cash And Equivalents Q1 2015 · May 31, 2013 $355.6M
Stockholders Equity Q1 2015 · Aug 31, 2014 $2.08B
Stockholders Equity Q1 2015 · May 31, 2014 $2.11B
Current Liabilities Q1 2015 · Aug 31, 2014 $725.4M
Current Liabilities Q1 2015 · May 31, 2014 $845.2M
Total Liabilities Q1 2015 · Aug 31, 2014 $7.52B
Total Liabilities Q1 2015 · May 31, 2014 $7.66B
Current Assets Q1 2015 · Aug 31, 2014 $1.78B
Current Assets Q1 2015 · May 31, 2014 $1.87B
Total Assets Q1 2015 · Aug 31, 2014 $9.6B
Total Assets Q1 2015 · May 31, 2014 $9.77B
Sga Expense Q1 2015 · Aug 31, 2014 $361.7M
Sga Expense restated Q1 2015 · Aug 31, 2013 $313.3M
Rd Expense Q1 2015 · Aug 31, 2014 $42.8M
Rd Expense Q1 2015 · Aug 31, 2013 $37.5M
Net Income Q1 2015 · Aug 31, 2014 $7.3M
Net Income Q1 2015 · Aug 31, 2013 $31.1M
Operating Income Q1 2015 · Aug 31, 2014 $82.5M
Operating Income Q1 2015 · Aug 31, 2013 $96.4M
Gross Profit Q1 2015 · Aug 31, 2014 $558.9M
Gross Profit restated Q1 2015 · Aug 31, 2013 $522.7M
Cost Of Revenue Q1 2015 · Aug 31, 2014 $215.9M
Cost Of Revenue restated Q1 2015 · Aug 31, 2013 $208M
Revenue Q1 2015 · Aug 31, 2014 $774.8M
Revenue Q1 2015 · Aug 31, 2013 $730.7M